ACI Submits Novel Foods Application to FSA on Behalf of CBD Safety Consortium
ACI have submitted their novel food application on behalf of the members of our CBD Safety Study Consortium. This marks a pivotal milestone for the ACI, whose members have been diligently working to meet the compliance deadline set by the UK’s Food Standards Agency (FSA).
[Canex] CBD Products to be Removed from Shelves as Novel Foods Deadline Looms
Despite the UK’s exit from the European Union and the end of the ‘transition period’ at the beginning of this year, it appears that the European Commission’s ruling on the novel status of CBD will stand. This means that all manufacturers and producers of CBD products in the UK will still be expected to have completed a Novel Foods application by the deadline later this year.
[Informa Pharma Insights] UK CBD Industry Embraces Trading Standards Partnership As Compliance Deadline Looms
UK CBD industry association, the ACI, joins others in forming partnerships with local authorities responsible for enforcing the new rules, which require all CBD food supplements on the market to hold a validated novel food application with the FSA.
[Food Navigator] ‘This will boost consumer confidence that they can trust these products’: CBD industry predicts sales lift as deadline for novel food applications approaches
With the UK deadline for Novel Food applications for CBD products approaching on March 31, industry body the Association for the Cannabinoid Industry (ACI) has announced a partnership with Trading Standards to ensure a smooth transition.
[Pharmacy Business Magazine] ACI forms partnership with Trading Standards
The Association for the Cannabinoid Industry (ACI) has announced on Tuesday (Feb 2) that it is the first UK cannabis industry association to formalise a partnership with Trading Standards. The latest agreement was approved by the Secretary of State last week.
2 Months Before FSA CBD Deadline ACI Forms Partnership with Trading Standards
ACI today announces it is the first UK cannabis industry association to formalise a partnership with Trading Standards. This agreement was approved by the Secretary of State last week.
Health Guidance Levels For THC: Safety Assessment and Regulatory Recommendations
This ACI members event will be hosted by Dr Parveen Bhatarah, ACI Regulatory and Compliance Associate, and Dr Paul Duffy, ACI Toxicology Associate. The webinar will cover: Overview of the project Key policy recommendations Gaps in existing scientific knowledge How this supports the industry Date: Monday 8 February 2021 Time: 4pm GMT This event is […]
ACI in Ongoing Discussions with European Commission Relating to Novel Foods
With the European Commission (EC) stating that they will begin assessing novel food dossiers on CBD again, ACI started 2021 by engaging the EC in constructive dialogue regarding our consortium approach to novel food applications.
[BusinessCann] Compliant CBD Companies Call For Crackdown On UK’s Novel Food ‘Refuseniks’
After cumulatively spending tens of millions of pounds on Novel Food compliance many UK CBD companies may be left feeling frustrated come the end of March deadline.
On April 1. the much-touted and controversial Novel Food rules come into place for businesses in the CBD supply chain.
ACI Responds to Letter From Kit Malthouse MP to ACMD Chair
ACI’s responds to a recent letter from Kit Malthouse MP, the Minister of State for Crime and Policing, to Professor Owen Bowden-Jones, the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
